Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment

F. C. Sciurba, R. A. Baumgartner, K. Sciarappa, R. P. Benzo, J. P. Hanrahan (Pittsburgh, PA, Marlborough, MA, United States Of America)

Source: Annual Congress 2007 - Treatment of COPD
Session: Treatment of COPD
Session type: Thematic Poster Session
Number: 596
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. C. Sciurba, R. A. Baumgartner, K. Sciarappa, R. P. Benzo, J. P. Hanrahan (Pittsburgh, PA, Marlborough, MA, United States Of America). Degree of exercise limitation in COPD: impact on 6 minute walk (6MW) in response to long-acting β-agonist (LABA) treatment. Eur Respir J 2007; 30: Suppl. 51, 596

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004

The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 577s
Year: 2005

Effects of exercise training on quality of life and 6 minute walk distance (6MWD) in adults with fixed airway obstruction asthma (FAOA)
Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing
Year: 2008

Patient-reported clinical control and peak-flow: Effects of 30 versus 6 month treatment with inhaled corticosteroids (ICS) with/without long-acting2-agonists (LABA) in moderately severe COPD
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011

Why do COPD patients improve six minute walking distance (6MWD) with the use of a rollator?
Source: Eur Respir J 2003; 22: Suppl. 45, 330s
Year: 2003

Effect of formoterol addition on dynamic hyperinflation during 6-minute walk test (6MWT) in moderate to severe COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


The influence of O2 on exercise capacity (6-minute-walking-distance, 6MWD) in COPD
Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation
Year: 2011

Effects of sildenafil on 6-minute walk distance (6MWD) and WHO functional class (FC) in pulmonary arterial hypertension (PAH) patients after 1 year of treatment
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008


Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT)
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


Effect of cold stimulation over face on 6 minute walk distance (6MWD), oxygen saturation and dyspnea scores in patients with COPD
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014

Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


Mechanism of improvement of exertional dyspnea during six minute walking test (6MWT) after pulmonary rehabilitation (PR) in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 719s
Year: 2005

Inhibitory effect of SABA on exercise dynamic lung hyperinflation during 6-min walk test in stable COPD patients
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011


Is a double 6-minute walk test (6MWT) required as part of the routine assessment of pulmonary rehabilitation (PR) in COPD patients?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


A single dose of tiotropium produces a significant improvement in 6-minute walk distance in severe COPD subjects
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Arm training: effects on ventilatory response to unsupported arm exercise (UAEx) in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 608s
Year: 2006

Improvements with tiotropium on endurance measured by the shuttle walking test (SWT) and on health related quality of life (HRQoL) in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 287s
Year: 2002

The effect of non-invasive ventilation (NIV) during exercise on inspiratory capacity (IC) and endurance time (Tlim) in patients with severe COPD
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019

The incremental shuttle walk test (ISW) in patients with bronchiectasis: Response to pulmonary rehabilitation (PR) and minimum clinically important difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019